We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+1.24%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.93B
AUM Growth
-$191M
Cap. Flow
-$51.4M
Cap. Flow %
-1.75%
Top 10 Hldgs %
43.92%
Holding
115
New
17
Increased
19
Reduced
24
Closed
19

Top Buys

Rank Stock Value
1
LEGN icon
Legend Biotech
LEGN
+$145M
2
IMTX icon
Immatics
IMTX
+$43.5M
3
RCKT icon
Rocket Pharmaceuticals
RCKT
+$38.6M
4
KO icon
Coca-Cola
KO
+$35.8M
5
CZR icon
Caesars Entertainment
CZR
+$30.6M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$78.3M
2
ACLX
Arcellx
ACLX
+$57.6M
3
RPRX icon
Royalty Pharma
RPRX
+$52.8M
4
T icon
AT&T
T
+$50.3M
5
UNH icon
UnitedHealth
UNH
+$40.7M

Sector Composition

Rank Sector Weight
1 Healthcare 55.9%
2 Consumer Discretionary 8.93%
3 Technology 8.81%
4 Financials 5.59%
5 Communication Services 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
76
Bristol-Myers Squibb
BMY
$132B
$1.91M 0.07%
+33,800
New +$1.89M
NTRA icon
77
Natera
NTRA
$46.4B
$1.6M 0.05%
10,100
– –
SYK icon
78
Stryker
SYK
$130B
$1.57M 0.05%
4,360
– –
AVTR icon
79
Avantor
AVTR
$9.19B
$1.51M 0.05%
71,850
– –
IQV icon
80
IQVIA
IQV
$39.3B
$1.41M 0.05%
7,175
– –
MDT icon
81
Medtronic
MDT
$112B
$1.39M 0.05%
17,460
– –
WAT icon
82
Waters Corp
WAT
$39.9B
$1.17M 0.04%
3,150
– –
MCK icon
83
McKesson
MCK
$101B
$1.04M 0.04%
1,830
– –
LKFT
84
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$1.02M 0.03%
37,111
-10,089
-21% -$281K
ELV icon
85
Elevance Health
ELV
$85.5B
$1.01M 0.03%
+2,740
New +$1.15M
HCA icon
86
HCA Healthcare
HCA
$89.5B
$957K 0.03%
3,190
– –
EW icon
87
Edwards Lifesciences
EW
$51.7B
$822K 0.03%
11,100
– –
A icon
88
Agilent Technologies
A
$41.2B
$670K 0.02%
4,990
– –
VLTO icon
89
Veralto
VLTO
$24B
$558K 0.02%
5,475
– –
RMD icon
90
ResMed
RMD
$30.7B
$547K 0.02%
2,390
– –
IONS icon
91
Ionis Pharmaceuticals
IONS
$9.4B
$378K 0.01%
10,800
– –
ZBH icon
92
Zimmer Biomet
ZBH
$18.4B
$344K 0.01%
3,260
– –
STE icon
93
Steris
STE
$23.1B
$315K 0.01%
1,530
– –
PACS icon
94
PACS Group
PACS
$7.67B
$262K 0.01%
20,000
– –
BAX icon
95
Baxter International
BAX
$14.2B
$232K 0.01%
7,970
– –
ALGN icon
96
Align Technology
ALGN
$12.3B
$229K 0.01%
1,100
– –
AAPL icon
97
Apple
AAPL
$4.57T
– –
-336,147
Closed -$78.3M
ACLX
98
DELISTED
Arcellx
ACLX
– –
-689,950
Closed -$57.6M
ALNY icon
99
Alnylam Pharmaceuticals
ALNY
$29.3B
– –
-13,824
Closed -$3.8M
CNTA
100
DELISTED
Centessa Pharmaceuticals
CNTA
– –
-70,000
Closed -$1.12M
1 2 3
4
5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Suvretta Capital Management held 115 positions worth $2.93B, down 6.1% from $3.13B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Suvretta Capital Management's Q4 2024 filing shows 17 new, 19 increased, 24 reduced and 19 closed positions. Its largest new stake was Legend Biotech: 3,496,234 shares worth $114M. The largest sale was Apple, an estimated $78.3M.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 53% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Suvretta Capital Management's largest Q4 2024 buy was Legend Biotech: 3,496,234 shares worth $114M.
  • Suvretta Capital Management added most to Coca-Cola in Q4 2024, an estimated $35.8M increase.
  • Suvretta Capital Management's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $40.7M.
  • Suvretta Capital Management fully exited Apple in Q4 2024, selling an estimated $78.3M.
  • Suvretta Capital Management's ten largest holdings make up 44% of its $2.93B portfolio in Q4 2024.
  • Suvretta Capital Management opened 17 new positions and closed 19 in Q4 2024.
  • Suvretta Capital Management's portfolio value fell 6.1% quarter-over-quarter to $2.93B.

Based on Suvretta Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.